Tokyo Tape
Sign in
← I'rom Group

Quarterly report · Q3

2372.TEDINET S100SRTF
Period2023-04-01 → 2023-12-31
Filed2024-02-08
StandardJapan GAAP
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 35
MetricValuePeriodScopeSource row
Revenue¥12.9bn2023-04-01 → 2023-12-31Cons.Net sales
Revenue¥18.4bn2022-04-01 → 2023-03-31Cons.Net sales (5-year summary)
Revenue¥13.9bn2022-04-01 → 2022-12-31Cons.Net sales
Operating income¥810m2023-04-01 → 2023-12-31Cons.Operating income
Operating income¥3.0bn2022-04-01 → 2022-12-31Cons.Operating income
Ordinary income¥1.1bn2023-04-01 → 2023-12-31Cons.Ordinary income
Ordinary income¥3.3bn2022-04-01 → 2023-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥2.9bn2022-04-01 → 2022-12-31Cons.Ordinary income
Profit before tax¥1.3bn2023-04-01 → 2023-12-31Cons.Income before income taxes
Profit before tax¥3.0bn2022-04-01 → 2022-12-31Cons.Income before income taxes
Net income (owners)¥972m2023-04-01 → 2023-12-31Cons.Profit loss attributable to owners of parent
Net income (owners)¥2.5bn2022-04-01 → 2023-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥2.2bn2022-04-01 → 2022-12-31Cons.Profit loss attributable to owners of parent
Net income¥972m2023-04-01 → 2023-12-31Cons.Profit loss
Net income¥2.2bn2022-04-01 → 2022-12-31Cons.Profit loss
Total assets¥36.5bnat 2023-12-31Cons.Assets
Total assets¥35.1bnat 2023-03-31Cons.Assets
Total assets¥32.2bnat 2022-12-31Cons.Total assets (5-year summary)
Total liabilities¥24.2bnat 2023-12-31Cons.Liabilities
Total liabilities¥23.0bnat 2023-03-31Cons.Liabilities
Net assets / equity¥12.4bnat 2023-12-31Cons.Net assets
Net assets / equity¥12.2bnat 2023-03-31Cons.Net assets
Net assets / equity¥11.8bnat 2022-12-31Cons.Net assets (5-year summary)
Cash and deposits¥7.3bnat 2023-12-31Cons.Cash and deposits
Cash and deposits¥9.4bnat 2023-03-31Cons.Cash and deposits
EPS (basic)¥80.332023-04-01 → 2023-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-9.892023-10-01 → 2023-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥210.222022-04-01 → 2023-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥185.132022-04-01 → 2022-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥21.052022-10-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (diluted)¥210.062022-04-01 → 2023-03-31Cons.Diluted earnings per share (5-year summary)
EPS (diluted)¥184.942022-04-01 → 2022-12-31Cons.Diluted earnings per share (5-year summary)
Equity ratio33.8%at 2023-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio34.6%at 2023-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio36.7%at 2022-12-31Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 64
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-12-31¥265m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-12-31¥224m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-12-31¥41m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-12-31−¥566m
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-12-31−¥3.5bn
Reconciling Itemsreconcilingrevenue external2023-04-01 → 2023-12-31¥0
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-12-31−¥3.5bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-12-31−¥1.4bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue2023-04-01 → 2023-12-31¥2.3bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue external2023-04-01 → 2023-12-31¥1.0bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥1.2bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentsegment profit2023-04-01 → 2023-12-31−¥130m
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue2023-04-01 → 2023-12-31¥5.4bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue external2023-04-01 → 2023-12-31¥4.4bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥938m
jpcrp040300-q3r_E05352-000CROreportable segmentsegment profit2023-04-01 → 2023-12-31¥51m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue2023-04-01 → 2023-12-31¥1.5bn
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue external2023-04-01 → 2023-12-31¥801m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥664m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentsegment profit2023-04-01 → 2023-12-31¥3m
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue2023-04-01 → 2023-12-31¥7.0bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue external2023-04-01 → 2023-12-31¥6.4bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue intersegment2023-04-01 → 2023-12-31¥617m
jpcrp040300-q3r_E05352-000SMOreportable segmentsegment profit2023-04-01 → 2023-12-31¥2.8bn
—segment totalrevenue2023-04-01 → 2023-12-31¥16.1bn
—segment totalrevenue external2023-04-01 → 2023-12-31¥12.6bn
—segment totalrevenue intersegment2023-04-01 → 2023-12-31¥3.4bn
—segment totalsegment profit2023-04-01 → 2023-12-31¥2.8bn
Total Of Reportable Segments And Otherssegment totalrevenue2023-04-01 → 2023-12-31¥16.4bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-04-01 → 2023-12-31¥12.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2023-04-01 → 2023-12-31¥3.5bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-04-01 → 2023-12-31¥2.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2022-04-01 → 2022-12-31¥101m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2022-04-01 → 2022-12-31¥55m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2022-04-01 → 2022-12-31¥46m
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2022-04-01 → 2022-12-31−¥67m
Reconciling Itemsreconcilingrevenue2022-04-01 → 2022-12-31−¥951m
Reconciling Itemsreconcilingrevenue external2022-04-01 → 2022-12-31¥2m
Reconciling Itemsreconcilingrevenue intersegment2022-04-01 → 2022-12-31−¥953m
Reconciling Itemsreconcilingsegment profit2022-04-01 → 2022-12-31−¥1.2bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue2022-04-01 → 2022-12-31¥1.0bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue external2022-04-01 → 2022-12-31¥1.0bn
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥2m
jpcrp040300-q3r_E05352-000Advanced Medicalreportable segmentsegment profit2022-04-01 → 2022-12-31−¥102m
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue2022-04-01 → 2022-12-31¥4.1bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue external2022-04-01 → 2022-12-31¥4.0bn
jpcrp040300-q3r_E05352-000CROreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥97m
jpcrp040300-q3r_E05352-000CROreportable segmentsegment profit2022-04-01 → 2022-12-31−¥70m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue2022-04-01 → 2022-12-31¥1.5bn
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue external2022-04-01 → 2022-12-31¥818m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥691m
jpcrp040300-q3r_E05352-000Medical Supportreportable segmentsegment profit2022-04-01 → 2022-12-31¥72m
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue2022-04-01 → 2022-12-31¥8.1bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue external2022-04-01 → 2022-12-31¥8.0bn
jpcrp040300-q3r_E05352-000SMOreportable segmentrevenue intersegment2022-04-01 → 2022-12-31¥115m
jpcrp040300-q3r_E05352-000SMOreportable segmentsegment profit2022-04-01 → 2022-12-31¥4.4bn
—segment totalrevenue2022-04-01 → 2022-12-31¥14.7bn
—segment totalrevenue external2022-04-01 → 2022-12-31¥13.8bn
—segment totalrevenue intersegment2022-04-01 → 2022-12-31¥907m
—segment totalsegment profit2022-04-01 → 2022-12-31¥4.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2022-04-01 → 2022-12-31¥14.8bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-04-01 → 2022-12-31¥13.9bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2022-04-01 → 2022-12-31¥953m
Total Of Reportable Segments And Otherssegment totalsegment profit2022-04-01 → 2022-12-31¥4.2bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 410
ItemContextValueUnit
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E05352-000CROReportableSegmentMember938000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E05352-000AdvancedMedicalReportableSegmentsMember1222000000JPY
Transactions with other segmentsCurrentYTDDuration_jpcrp040300-q3r_E05352-000MedicalSupportReportableSegmentsMember664000000JPY
Transactions with other segmentsCurrentYTDDuration_ReportableSegmentsMember3443000000JPY
Transactions with other segmentsCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember41000000JPY
Transactions with other segmentsCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember3484000000JPY
Transactions with other segmentsCurrentYTDDuration_ReconcilingItemsMember-3484000000JPY
Transactions with other segmentsCurrentYTDDuration－JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E05352-000SMOReportableSegmentsMember6991000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E05352-000CROReportableSegmentMember5357000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E05352-000AdvancedMedicalReportableSegmentsMember2272000000JPY
Net salesCurrentYTDDuration_jpcrp040300-q3r_E05352-000MedicalSupportReportableSegmentsMember1465000000JPY
Net salesCurrentYTDDuration_ReportableSegmentsMember16086000000JPY
Net salesCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember265000000JPY
Net salesCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember16352000000JPY
Net salesCurrentYTDDuration_ReconcilingItemsMember-3484000000JPY
Net salesCurrentYTDDuration12868000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E05352-000SMOReportableSegmentsMember2839000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E05352-000CROReportableSegmentMember51000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E05352-000AdvancedMedicalReportableSegmentsMember-130000000JPY
Operating incomeCurrentYTDDuration_jpcrp040300-q3r_E05352-000MedicalSupportReportableSegmentsMember3000000JPY
Operating incomeCurrentYTDDuration_ReportableSegmentsMember2764000000JPY
Operating incomeCurrentYTDDuration_OperatingSegmentsNotIncludedInReportableSegmentsAndOtherRevenueGeneratingBusinessActivitiesMember-566000000JPY
Operating incomeCurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember2197000000JPY
Operating incomeCurrentYTDDuration_ReconcilingItemsMember-1387000000JPY
Operating incomeCurrentYTDDuration810000000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)四半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の４の７第１項
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2024-02-08
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第27期第３四半期（自　2023年10月１日　至　2023年12月31日）
Company name cover pageFilingDateInstant
Original text (Japanese)株式会社アイロムグループ
Company name in english cover pageFilingDateInstantI'rom Group Co., Ltd.
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長　　森　豊隆
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都千代田区富士見二丁目10番２号
Telephone number address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)03（3264）3148（代表）
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)取締役　金融・経営管理センター長　菅原　明彦
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都千代田区富士見二丁目10番２号
Telephone number nearest place of contact cover pageFilingDateInstant
Original text (Japanese)03（3264）3148（代表）
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)取締役　金融・経営管理センター長　菅原　明彦
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE05352
Fund codeFilingDateInstant－
Security codeFilingDateInstant23720
Filer name in japaneseFilingDateInstant
Original text (Japanese)株式会社アイロムグループ
Filer name in englishFilingDateInstantI'rom Group Co., Ltd.
Fund name in japaneseFilingDateInstant－
Fund name in englishFilingDateInstant－
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2023-03-31pass rounding
balance sheet identityconsolidated 2023-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2023-03-31pass
statement vs summary · net assetsconsolidated 2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2022-04-01/2022-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-12-31pass
statement vs summary · revenueconsolidated 2022-04-01/2022-12-31pass
statement vs summary · revenueconsolidated 2023-04-01/2023-12-31pass
statement vs summary · total assetsconsolidated 2023-03-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass